Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
348.06
+6.40 (1.87%)
At close: Jun 18, 2026, 4:00 PM EDT
347.00
-1.06 (-0.30%)
After-hours: Jun 18, 2026, 6:50 PM EDT
Krystal Biotech Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Krystal Biotech stock has a consensus rating of "Strong Buy" and an average price target of $339.22. The average 1-year stock price forecast is 2.54% lower than the current stock price, while the lowest is $241 (-30.76%) and the highest is $403 (+15.78%).
Price Target: $339.22 (-2.54%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Krystal Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 10 | 10 | 10 | 10 | 10 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $306 → $403 | Buy | Maintains | $306 → $403 | +15.78% | Jun 18, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $310 → $361 | Buy | Reiterates | $310 → $361 | +3.72% | Jun 16, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $364 | Buy | Maintains | $364 | +4.58% | Jun 1, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 18, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $295 → $300 | Buy | Maintains | $295 → $300 | -13.81% | May 5, 2026 |
Financial Forecast
Revenue This Year
525.24M
from 389.13M
Increased by 34.98%
Revenue Next Year
677.61M
from 525.24M
Increased by 29.01%
EPS This Year
8.29
from 6.84
Increased by 21.22%
EPS Next Year
10.08
from 8.29
Increased by 21.53%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 549.9M | ||
| Avg | 525.2M | ||
| Low | 494.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 41.3% | ||
| Avg | 35.0% | ||
| Low | 26.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.52 | ||
| Avg | 8.29 | ||
| Low | 6.21 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 112.3% | ||
| Avg | 21.2% | ||
| Low | -9.2% |